Jul 18, 2025 · 24m · tbpn
E-Cigarettes: Now FDA-Approved?
0:00 / 0:00
▶ Watch on YouTube →
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
John Coogan examines the business history, scientific innovation, and regulatory framework of the e-cigarette industry following Juul's FDA authorization. The discussion explores how federal oversight, Supreme Court precedent, and Big Tobacco moats shape modern nicotine products.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. The hosts hold 84.1% of the talking time here. How this is scored →
The hosts as informed peer 8.3 Guest teaching 0.2 Guest disagreement 0.2 The hosts pushing back 0.2
speaking balance: gold is the hosts, purple is the guest (3 minute bins)
Sharpest disagreement ▶ 21:58 Co-host pointing out commodity nature of nicotine gum
The co-host playfully pushes back on product differentiation by pointing out that despite small formula tweaks, both products remain just gum.
Hardest push from the hosts ▶ 8:59 Reframing regulatory capture into distribution mechanicsJohn gently reframes the co-host's assumption that margins exist solely from regulatory capture by detailing retail slotting, delivery trucks, and power wall agreements.
Biggest teaching moment ▶ 23:09 Co-host sharing VC investor perspective on nicotine pitchesThe co-host provides direct investor perspective on vetting a novel synthetic nicotine pitch and realizing the regulatory hurdles made it unviable.
The host holds their own ▶ 19:40 Founder perspective on 2016 deeming rule pre-market windowJohn leverages firsthand operator expertise to explain why building Lucy post-2016 without pre-market authorization would be economically impossible.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | The hosts as informed peer | Guest teaching | Guest disagreement | The hosts pushing back | Why |
|---|---|---|---|---|---|---|
| Juul FDA Authorization and Illicit Vape Market | 8 | 0 | 0 | 0 | John opens with precise regulatory context regarding Juul's FDA marketing granted orders (MGOs) versus standard drug approvals. The co-host acts purely collaboratively, prompting John on the illicit vape market. | |
| The Stanford Origins and Science of Juul | 8 | 0 | 0 | 0 | John details the chemical and technological formulation of nicotine salts and the early industrial design history of Juul. The co-host shares nostalgic anecdotes about early vape culture. | |
| Pax Separation and FDA Regulatory Architecture | 9 | 0 | 1 | 1 | John provides an expansive historical breakdown spanning FDA organizational divisions, JP Morgan, Warren Buffett quotes, and the Master Settlement Agreement. When the co-host attributes high margins purely to regulatory capture, John refines the point with details on retail power wall distribution. | |
| Federal Advertising Bans and Out-of-Home Marketing | 8 | 0 | 0 | 0 | John recounts the legal trajectory of Njoy, including Supreme Court jurisprudence, FDA import bans, and private equity restructuring. The co-host supports the narrative with humorous remarks. | |
| The Tobacco Control Act and PMTA Implementation | 9 | 0 | 0 | 0 | John explains the passage of the 2008 Tobacco Control Act, FDA staffing requirements, and the mechanics of the 2016 PMTA deeming rule grace period in extensive detail with minimal interruption. | |
| Startup Challenges Under Modern FDA Nicotine Regulations | 8 | 1 | 0 | 0 | John discusses his direct experience founding Lucy before the 2016 deadline and the harsh capital requirements of the modern nicotine regulatory regime. The co-host shares an anecdote about reviewing a synthetic nicotine pitch. |
Statements from this episode (9)
FDA authorized Juul via Marketing Granted Orders after net positive health review
“The FDA has issued marketing granted orders. These are MGOs. We'll get into this, but it's, like, slightly different than, like, FDA approval for a drug for the Juul system, recognizing that these products, as appropriate for the protection of public health, t…”
Juul founders used nicotine salts to concentrate vapor and satisfy smokers
“Adam Bowen, James Monthe is the founders of Jewel. They figured out that they, there was a way to make the smoke or the vapor more concentrated. And there's a whole bunch of science that goes into it, but nicotine salts are like the main one that people point …”
Pax and Juul split companies due to divergent regulatory and commercial paths
“Then they wind up splitting the company once both products are kind of taking off, but they're on very, very different trajectories. And it's very clear that They will be under very different regulatory regimes”
Big Tobacco controls retail moats via logistics and cashier power walls
“One is there's actually distribution monopolies because all the big tobacco companies have trucks that go and deliver them to tobacco stores that are licensed. And so, If you have a set amount of tobacco store licenses, like gas stations that have a tobacco li…”
Local governments securitize tobacco settlement payouts to finance public infrastructure projects
“Basically they have to make all these payments and these payments still happen today. And there's some interesting finance that goes on where if you're like a local county, that's getting like cashflow from the tobacco companies, you can go and finance that ou…”
FDA import restrictions on overseas manufacturing bankrupted early e-cigarette maker NJOY
“The FDA is able to put an import restriction on the company, so they're making the product, I believe, in China, probably overseas somewhere, because it's electronics, it's equipment. They bring it in at the ports, and the FDA says, hey, while we sort out this…”
Investor bought NJOY out of bankruptcy, secured FDA approval, sold to Altria
“Later, a hedge fund guy actually buys the company out of bankruptcy, turns it around, gets it FDA approved, and sells it to Altria for like a couple hundred million dollars, or maybe actually a couple billion dollars, I think.”
FDA created regulatory grace period for nicotine products launched before August 2016
“Going forward, new products that contain nicotine, that contain tobacco, We want to review it before it hits the market, but we're also going to create a grace period for stuff that was launched before 2016. Anything launched before August eight, 20 16. You ca…”
Nicotine startup Lucy spent millions and a decade awaiting FDA approval
“You could spend millions of dollars and wait a decade, which is exactly what we did. But we were able to actually grow the brand and sell the product and like set up operations and iron out things and iterate a little bit during that time, fortunately.”